Joséphine Pressacco

Treatment With 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) in Patients With Recent Acute Coronary Syndrome

Jean‐Claude Tardif, Philippe L. L’Allier, Réda Ibrahim et al. · Circulation Cardiovascular Imaging · 2010 · 155 citations

Medicine, Pharmacology, Pharmacotherapy +17

Cardiac masses: an integrative approach using echocardiography and other imaging modalities

Dominique Auger, Joséphine Pressacco, F Marcotte et al. · Heart · 2011 · 79 citations

Medicine, Cardiology, Radiology +17

Effects of the Tumor Necrosis Factor-α Antagonist Adalimumab on Arterial Inflammation Assessed by Positron Emission Tomography in Patients With Psoriasis

Robert Bissonnette, Jean‐Claude Tardif, François Harel et al. · Circulation Cardiovascular Imaging · 2012 · 75 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Radiology in the Era of Value-based Healthcare: A Multi-Society Expert Statement from the ACR, CAR, ESR, IS3R, RANZCR, and RSNA

Adrian P. Brady, Jaqueline A. Bello, Lorenzo E. Derchi et al. · Radiology · 2020 · 71 citations · Full text

Public Affairs, Health Policy, Radiology +17

Effect of treatment with 5‐lipoxygenase inhibitor <scp>VIA</scp>‐2291 (atreleuton) on coronary plaque progression: a serial <scp>CT</scp> angiography study

Suguru Matsumoto, Réda Ibrahim, Jean C. Grégoire et al. · Clinical Cardiology · 2016 · 42 citations · Full text

Medicine, Cardiology, Pharmacology +17